It has been announced that Shaare Zedek doctor Nathan Cherny is the recipient of an award from The European Society for Medical Oncology (ESMO).  Doctor Cherny is a founder of the ESMO Palliative Care Working Group and  has played a key role in introducing palliative care into the medical oncology curriculum.
The acclaimed ESMO Award was established in 1985 to annually recognise an ESMO member who has made an outstanding contribution to the development of medical oncology and who understands the importance of promoting medical oncology as a specialty within the international community

Speaking about his award Cherny said: “This award acknowledges that ESMO prioritises the promotion of care, the relief of suffering and distress as a central part of the oncological endeavour, the importance of healthy scepticism and scientific curiosity and the critical importance of professionalism and professional integrity. That ESMO and the oncology community value these things as much as I is truly and deeply gratifying.”

“I wish to dedicate this award to the promotion of care, the pursuit of peace and understanding between peoples, and the ongoing challenge for making the best possible care available and affordable to all,” said Cherny.

The award will be presented at the European Cancer Congress 2015, held 25-29 September in Vienna, Austria.1

Hear more about our hospital and activities here in the UK

* indicates required

Shaare Zedek UK will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can change your mind at any time by clicking the unsubscribe link in the footer of any email you receive from us, or by contacting us at We will treat your information with respect. For more information about our privacy practices please click here. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.